ClinConnect ClinConnect Logo
Search / Trial NCT06760572

Airway Data Collection With the Entarik Feeding Tube System

Launched by THERANOVA, L.L.C. · Dec 31, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Feeding Tube Feeding Tube Placement Safety Feeding Tube Placement

ClinConnect Summary

This clinical trial is looking at a new device called the Entarik Feeding Tube System. The main goal is to see how well this device can detect if it is placed in the airway, which is important for safely feeding patients. The study will collect information to help improve the device, and it will involve adults who are scheduled to have a procedure called bronchoscopy, where they will be intubated (given a breathing tube) as part of their regular medical care.

To participate in this trial, you need to be at least 18 years old and able to give your permission to join. You must also be scheduled for the bronchoscopy procedure. However, there are some reasons you might not be able to join, such as having certain breathing problems, active infections, or specific medical conditions. If you decide to participate, you’ll help researchers gather important data that could lead to improvements in how feeding tubes are used. The trial is not yet recruiting participants, but it is important to know that your safety and comfort will be prioritized throughout the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. At least 18 years old.
  • 2. Able to provide informed consent.
  • 3. Adults scheduled to undergo a bronchoscopy procedure who will be intubated as part of the standard of care.
  • Exclusion Criteria:
  • 1. Known major upper airway malformation.
  • 2. Presence of clinically significant respiratory infection.
  • 3. Known bleeding disorder.
  • 4. Currently pregnant.
  • 5. Current basilar skull fracture.
  • 6. Known sensitivities or allergies to the feeding tube components.
  • 7. Deemed unsuitable for enrollment in study by the investigator based on subject's history (e.g., active anticoagulation therapy) or physical examination.

About Theranova, L.L.C.

Theranova, L.L.C. is a clinical trial sponsor dedicated to advancing innovative therapeutic solutions through rigorous research and development. Committed to improving patient outcomes, Theranova specializes in the design and execution of clinical studies across various therapeutic areas, leveraging cutting-edge methodologies and technology. The company collaborates with healthcare professionals, regulatory bodies, and research institutions to ensure the highest standards of scientific integrity and patient safety. With a focus on transparency and ethical practices, Theranova aims to contribute significantly to the advancement of medical science and the development of new treatment options.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Daniel Burnett, MD

Study Director

Theranova, LLC

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported